...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Equity offering
5
Jun 04, 2018 04:39PM
3
Jun 04, 2018 04:51PM
4
Jun 04, 2018 05:21PM

masila - If it is ZCC yes they will be entitled to the royalty stream.

tada

5
Jun 06, 2018 01:49PM
Share
New Message
Please login to post a reply